Evidence map›Paper›PMID 36821088›Full record

ArticleThe Journal of cell biology2023

PERK recruits E-Syt1 at ER-mitochondria contacts for mitochondrial lipid transport and respiration.

Maria Livia Sassano, Alexander R van Vliet, Ellen Vervoort, Sofie Van Eygen, Chris Van den Haute, Benjamin Pavie, Joris Roels, Johannes V Swinnen, Marco Spinazzi, Leen Moens and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of cell biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Rab14 promotes Parkin-mediated mitophagy.Molecular biology of the cell · 2025
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 3 countries.

Maria Livia SassanoCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.ORCID 0000-0002-2262-6915
Alexander R van VlietCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.ORCID 0000-0003-4729-4379
Ellen VervoortCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.ORCID 0000-0001-5031-3150
Sofie Van EygenCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.ORCID 0000-0003-4073-9523
Chris Van den HauteResearch Group for Neurobiology and Gene Therapy, Department of Neuroscience, Leuven Viral Vector Core, KU Leuven , Leuven, Belgium.ORCID 0000-0002-6650-3845
Benjamin PavieVIB-bioimaging Center UGent , Ghent, Belgium.ORCID 0000-0002-0249-3844
Joris RoelsVIB-bioimaging Center UGent , Ghent, Belgium.ORCID 0000-0002-2058-8134
Johannes V SwinnenLaboratory of Lipid Metabolism and Cancer, Department of Oncology, KU Leuven , Leuven, Belgium.ORCID 0000-0002-7720-5077
Marco SpinazziNeuromuscular Reference Center, CHU Angers , Angers, France.ORCID 0000-0003-0048-9558
Leen MoensLaboratory for Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, Department of Pediatrics, University Hospitals Leuven , Leuven, Belgium.ORCID 0000-0002-5347-6526
Kristina CasteelsWoman and Child, Department for Development and Regeneration, KU Leuven, Department of Pediatrics, University Hospitals Leuven , Leuven, Belgium.ORCID 0000-0001-9690-3551
Isabelle MeytsLaboratory for Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, Department of Pediatrics, University Hospitals Leuven , Leuven, Belgium.ORCID 0000-0003-1214-0302
Paolo PintonDepartment of Medical Sciences, University of Ferrara , Ferrara, Italy.ORCID 0000-0001-7108-6508
Saverio MarchiDepartment of Clinical and Molecular Sciences, Marche Polytechnic University , Ancona, Italy.ORCID 0000-0003-2708-1843
Leila RochinInserm , Gif-sur-Yvette, France.ORCID 0000-0003-3311-084X
Francesca GiordanoInserm , Gif-sur-Yvette, France.ORCID 0000-0002-5942-1753
Blanca Felipe-AbrioCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.ORCID 0000-0001-7025-3247
Patrizia AgostinisCell Death Research and Therapy Group, Department of Cellular and Molecular Medicine, KU Leuven , Leuven, Belgium.ORCID 0000-0003-1314-2115
VIB-KU Leuven Center for Cancer Biology · BEKU Leuven · BEInserm · FRCentre Hospitalier Universitaire d'Angers · FRCentre National de la Recherche Scientifique · FRGhent University · BEMarche Polytechnic University · ITUniversity of Ferrara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The integrity of ER-mitochondria appositions ensures transfer of ions and phospholipids (PLs) between these organelles and exerts crucial effects on mitochondrial bioenergetics. Malfunctions within the ER-mitochondria contacts altering lipid trafficking homeostasis manifest in diverse pathologies, but the molecular effectors governing this process remain ill-defined. Here, we report that PERK promotes lipid trafficking at the ER-mitochondria contact sites (EMCS) through a non-conventional, unfolded protein response-independent, mechanism. PERK operates as an adaptor for the recruitment of the ER-plasma membrane tether and lipid transfer protein (LTP) Extended-Synaptotagmin 1 (E-Syt1), within the EMCS. In resting cells, the heterotypic E-Syt1-PERK interaction endorses transfer of PLs between the ER and mitochondria. Weakening the E-Syt1-PERK interaction or removing the lipid transfer SMP-domain of E-Syt1, compromises mitochondrial respiration. Our findings unravel E-Syt1 as a PERK interacting LTP and molecular component of the lipid trafficking machinery of the EMCS, which critically maintains mitochondrial homeostasis and fitness.

Indexed as

eIF-2 KinaseMitochondriaMitochondrial MembranesPhospholipidsSynaptotagmin IBiological TransportHumansLipid MetabolismEIF2AK3 protein, humaneIF-2 KinasePhospholipidsSynaptotagmin ISYT1 protein, human

Identifiers

PMID36821088
PMCPMC9998969
OpenAlexW4321610912

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.